We are live on
!
Find out more
CCMW
Cypress Capital Management (Wyoming) Portfolio holdings
AUM
$108M
1-Year Est. Return
54.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.49%
1 Year Est. Return
+54.47%
3 Year Est. Return
+138.31%
5 Year Est. Return
+183.27%
10 Year Est. Return
+648.96%
AUM
$99.5M
AUM Growth
+$4.13M
(+4.3%)
Cap. Flow
+$1.74M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
34.72%
Holding
384
New
63
Increased
66
Reduced
53
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Onto Innovation
ONTO
|
+$887K |
| 2 |
Rayonier
RYN
|
+$723K |
| 3 |
AMED
Amedisys
AMED
|
+$666K |
| 4 |
Immersion
IMMR
|
+$584K |
| 5 |
PGTI
PGT, Inc.
PGTI
|
+$531K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$1.74M |
| 2 |
TVRD
Tvardi Therapeutics
TVRD
|
+$1.49M |
| 3 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$1.19M |
| 4 |
Micron Technology
MU
|
+$1.1M |
| 5 |
SM Energy
SM
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.15% |
| 2 | Consumer Staples | 8.4% |
| 3 | Industrials | 8.18% |
| 4 | Financials | 6.43% |
| 5 | Healthcare | 5.51% |
Similar funds
GCCM
PCC
PFG
IPS
FA
HPM
SFAM
HSM
Cypress Capital Management (Wyoming)'s Q3 2018 Portfolio in Review
As of Q3 2018, Cypress Capital Management (Wyoming) held 384 positions worth $99.5M, up 4.3% from $95.3M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Cypress Capital Management (Wyoming)'s Q3 2018 filing shows 63 new, 66 increased, 53 reduced and 40 closed positions. Its largest new stake was Rayonier: 22,568 shares worth $377K. The largest sale was Edwards Lifesciences, an estimated $1.74M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Industrials.
- Cypress Capital Management (Wyoming)'s largest Q3 2018 buy was Rayonier: 22,568 shares worth $377K.
- Cypress Capital Management (Wyoming) added most to Onto Innovation in Q3 2018, an estimated $887K increase.
- Cypress Capital Management (Wyoming)'s biggest Q3 2018 reduction was Micron Technology, cutting an estimated $1.1M.
- Cypress Capital Management (Wyoming) fully exited Edwards Lifesciences in Q3 2018, selling an estimated $1.74M.
- Cypress Capital Management (Wyoming)'s ten largest holdings make up 35% of its $99.5M portfolio in Q3 2018.
- Cypress Capital Management (Wyoming) opened 63 new positions and closed 40 in Q3 2018.
- Cypress Capital Management (Wyoming)'s portfolio value rose 4.3% quarter-over-quarter to $99.5M.
Based on Cypress Capital Management (Wyoming)'s 13F filing for Q3 2018, filed 31 Oct 2018.